Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to -$89000.0.

  • International Stem Cell's Other Working Capital Changes rose 7834.55% to -$89000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$334000.0, marking a year-over-year increase of 4506.58%. This contributed to the annual value of -$276000.0 for FY2024, which is 2052.4% down from last year.
  • Latest data reveals that International Stem Cell reported Other Working Capital Changes of -$89000.0 as of Q3 2025, which was up 7834.55% from -$326000.0 recorded in Q2 2025.
  • International Stem Cell's Other Working Capital Changes' 5-year high stood at $263000.0 during Q1 2021, with a 5-year trough of -$496000.0 in Q3 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$50000.0 (2022), whereas its average is -$67736.8.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 31904.76% in 2022, then plummeted by 1640000.0% in 2025.
  • International Stem Cell's Other Working Capital Changes (Quarter) stood at -$88000.0 in 2021, then soared by 43.18% to -$50000.0 in 2022, then plummeted by 710.0% to -$405000.0 in 2023, then skyrocketed by 81.98% to -$73000.0 in 2024, then decreased by 21.92% to -$89000.0 in 2025.
  • Its Other Working Capital Changes stands at -$89000.0 for Q3 2025, versus -$326000.0 for Q2 2025 and $154000.0 for Q1 2025.